<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://mn.medsurfnews.com</link><description>Le ultime risorse da Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthwaregroup.com</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://mn.medsurfnews.com/images/logo.jpg</url><link>http://mn.medsurfnews.com</link></image>

	
	
<item>

<title>Rosuvastatin and atorvastatin against atheroma</title>
<link>http://mn.medsurfnews.com/contents/it/7304/display/rosuvastatin-and-atorvastatin-against-atheroma.aspx</link>
<pubDate>Mon, 28 May 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[Based on the results of previous studies, we know that the use of high-dose statins can reduce coronary artery plaque thickness. Researchers have recently used an intravascular ultrasound probe to monitor changes in coronary plaque volume in a randomized comparison of rosuvastatin (40 mg daily) and [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7304_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7304_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Prognosis of asymptomatic bradycardia</title>
<link>http://mn.medsurfnews.com/contents/it/7291/display/prognosis-of-asymptomatic-bradycardia.aspx</link>
<pubDate>Mon, 30 Apr 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[It is not uncommon to see elderly patients who have asymptomatic bradycardia, a condition for which a prognosis is not easy to formulate. To assess the real situation, a group of researchers examined all the ECGs performed in patients aged > 60 years between 1990 and 1995 from a single hospital. [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7291_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7291_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Delay in the treatment of STEMI</title>
<link>http://mn.medsurfnews.com/contents/it/7216/display/delay-in-the-treatment-of-stemi.aspx</link>
<pubDate>Mon, 23 Apr 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[Early treatment of a myocardial infarction with ST-segment elevation (STEMI) using fibrinolysis or percutaneous recanalization can decrease mortality. Apart from death, one of the possible complications of this situation is congestive heart failure. To investigate this, a group researchers in [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7216_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7216_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Warfarin-associated hemorrhage: the ATRIA study</title>
<link>http://mn.medsurfnews.com/contents/it/7206/display/warfarin-associated-hemorrhage-the-atria-study.aspx</link>
<pubDate>Mon, 9 Apr 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[With a patient experiencing atrial fibrillation (AF), the decision to start therapy with warfarin obviously depends on the balance between risks of hemorrhage and benefits. In this study involving 9,186 patients with AF receiving anticoagulation, 5 factors predictive of risk for major hemorrhage [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7206_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7206_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Chocolate and cardiovascular events</title>
<link>http://mn.medsurfnews.com/contents/it/7201/display/chocolate-and-cardiovascular-events.aspx</link>
<pubDate>Mon, 2 Apr 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[All products of the cocoa tree contain polyphenols, which have beneficial effects on the cardiovascular system. To evaluate the association of chocolate consumption with the risk of developing cardiometabolic disorders, researchers developed a meta-analysis of seven observational studies involving [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7201_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7201_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Apixaban versus warfarin (the ARISTOTLE study)</title>
<link>http://mn.medsurfnews.com/contents/it/7158/display/apixaban-versus-warfarin-the-aristotle-study.aspx</link>
<pubDate>Mon, 26 Mar 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[Although the benefits of warfarin in the prevention of thromboembolic ischemic events is unquestionable, it is equally true that this drug’s therapeutic window is very narrow, and that the necessity of its monitoring makes adherence to therapy, which include strict dietary restrictions, not easy. [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7158_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7158_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Holter monitoring for the diagnosis of hypertension</title>
<link>http://mn.medsurfnews.com/contents/it/7155/display/holter-monitoring-for-the-diagnosis-of-hypertension.aspx</link>
<pubDate>Mon, 19 Mar 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[Based on the results of previous studies, 24-hour blood pressure monitoring is related to cardiovascular events more than home or ambulatory measurements, although Holter pressure monitoring is normally limited to cases where the diagnosis of hypertension is to be ascertained. Obviously, the [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7155_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7155_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Rivaroxaban in the prevention of stroke</title>
<link>http://mn.medsurfnews.com/contents/it/7147/display/rivaroxaban-in-the-prevention-of-stroke.aspx</link>
<pubDate>Mon, 12 Mar 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[In patients with atrial fibrillation (AF) the use of an oral factor Xa inhibitor – rivaroxaban – can be an alternative to warfarin for the secondary prevention of stroke. The ROCKET study compared rivaroxaban with warfarin in patients with non-valvular AF: the study was a multicenter, double-blind, [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7147_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7147_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>When sould we talk of hypertension?</title>
<link>http://mn.medsurfnews.com/contents/it/7143/display/when-sould-we-talk-of-hypertension.aspx</link>
<pubDate>Mon, 5 Mar 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[When evaluating a patient for hypertension, the clinician generally bases his assessment on pressure measurements performed either at his office or at home by the patient himself, although it is unclear how reliable these measurements are for diagnostic purposes. This systematic review, followed by [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7143_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7143_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	
<item>

<title>Alcohol and cardiovascular risk</title>
<link>http://mn.medsurfnews.com/contents/it/7067/display/alcohol-and-cardiovascular-risk.aspx</link>
<pubDate>Mon, 27 Feb 2012 12:00:00 +0200</pubDate>
<category>Cardiologia</category>
<description><![CDATA[A meta-analysis involving 84 prospective studies (total number of participants was over 1 million) evaluated the effect of alcohol on mortality from cardiovascular disease and from stroke, and its incidence on coronary heart disease in general. Median follow-up was 11 years. After the customary [...]]]></description>

<enclosure url="http://mn.medsurfnews.com/mp3/7067_fast.mp3" type="audio/mpeg" length=""/>


<enclosure url="http://mn.medsurfnews.com/mp3/7067_slow.mp3" type="audio/mpeg" length=""/>
		
</item>	
	
	
	
	
	</channel></rss>
	



